Skip to main content

UNITED THERAPEUTICS Corp 8-K, filed Nov 4, 2026

UNITED THERAPEUTICS Corp (UTHR)

8-K 2026-11-04 For: 2026-11-04
View Original
Added on November 04, 2026

About this 8-K

UNITED THERAPEUTICS Corp filed this 8-K on November 4, 2026.

United Therapeutics reported $832.5 million in revenue for the quarter ended September 30, 2026, versus $799.5 million, while net income declined to $258.6 million from $338.7 million. AI summary

Items reported

  • Item 2.02: Financial results
  • Item 9.01: Financial statements and exhibits